Prospective randomized controlled trial investigating the type of sutures used during hepatectomy

Table 1 Comparison of clinicopathological data of the groups

Variables	Vicryl group	Silk group	P-value
	(n = 62)	(n = 63)
Age	68 ± 10	67 ± 12	0.684
Male/female	37/25	41/22	0.720
Body mass index	22.6 ± 3.0	23.7 ± 12	0.159
Diabetes mellitus (%)	19.4	33.0	0.104
HBV (%)	17.7	20.6	0.560
HCV (%)	50.0	39.7	0.666
Albumin (g/dL)	3.6 ± 0.5	3.6 ± 0.5	0.694
Total bilirubin (mg/dL)	0.7 ± 0.4	0.7 ± 0.4	0.813
AST (IU/L)	46 ± 31	43 ± 27	0.592
Platelet count (x 104/μL)	21.0 ± 11.0	19.7 ± 10.1	0.460
ICGR15 (%)	15.4 ± 9.0	16.4 ± 11.9	0.589
Child-Pugh A/B	58/4	59/4	0.999
HCC/non-HCC	46/16	47/16	0.826
Liver cirrhosis (ch/lf/lc)	15/20/27	15/22/26	0.948
Anatomical/nonanatomical	20/42	20/43	0.618
Operation time (min)	273 ± 88	276 ± 105	0.876
Blood loss (g)	698 ± 894	763 ± 1329	0.749
Transfusion (%)	12.9	17.4	0.620
Bile leakage (%)	3.2	6.3	0.680
Total SSI (%)	11.3	15.8	0.603
Incisional SSI (%)	8.0	9.5	0.999
Organ/space SSI (%)	3.2	6.3	0.680
Remote infection (%)	3.2	1.6	0.546
Hospital stay (d)	16 ± 15	16 ± 14	0.880

SSI: Surgical site infection; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; AST: Aspartate aminotransferase.